Law360, London (July 22, 2021, 5:10 p.m. BST) – A London judge on Thursday denied medical device maker Insulet permission to appeal a ruling that pharmaceutical giant Roche did not prematurely start selling pumps tubeless insulin before patent expires.
Pat Treacy, serving as a High Court judge, concluded that Insulet had no real chance of overturning its previous ruling freeing Roche from patent infringement claims on its line of insulin pumps.
According to the ruling, Insulet planned to argue that every aspect of the judge’s previous ruling contained “an error in principle, law and / or interpretation.” The judge said if Insulet wanted to appeal these …
Stay one step ahead
In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas, and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.
Access to case data in articles (numbers, filings, courts, nature of prosecution, etc.)
Access to attached documents such as briefs, petitions, complaints, decisions, requests, etc.
Create personalized alerts for specific case articles and topics and more!